During the past decade, Keogh Institute for Medical Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Keogh Institute for Medical Research" #1 sponsor was "Daré Bioscience, Inc." with 3 trials, followed by "Crinetics Pharmaceuticals Inc." with 2 trials sponsored, "DiObex" with 2 trials sponsored, "Acerus Pharmaceuticals Corporation" with 1 trials sponsored and "Endo Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Keogh Institute for Medical Research" #1 collaborator was "HealthCore-NERI" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator and "PHT Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Keogh Institute for Medical Research" are "Type 2 Diabetes" (3 trials), "Acromegaly" (2 trials), "Vasomotor Symptoms" (2 trials), "Vulvovaginal Atrophy" (2 trials) and "Female Orgasmic Disorder" (1 trials). Many other conditions were trialed in "Keogh Institute for Medical Research" in a lesser frequency.

Most popular intervention types in "Keogh Institute for Medical Research" are "Drug" (10 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "DIO-902" (2 trials), "IVR Dose 1" (2 trials), "IVR Dose 2" (2 trials) and "Paltusotine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Keogh Institute for Medical Research" are 5 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Keogh Institute for Medical Research". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Keogh Institute for Medical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Keogh Institute for Medical Research, 3 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".